Additionally, in some tumour or osteoarthritis studies [26, 27], the downregulation of CPT1A has been shown to inhibit cell ageing, leading us to speculate that the role of CPT1A may vary in different cell types due to differences in the metabolic pathways involved, the cellular environment and the physiological or pathological pressures faced. Here, CPT1A is linked to neoplasm.